Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)

Juan Li; Jie Liu; Zheyong Liang; Fang He; Lu Yang; Pingping Li; Yina Jiang; Bo Wang; Can Zhou; Yaochun Wang; Yu Ren; Jin Yang; Jianmin Zhang; Zhijun Luo; Cyrus Vaziri; Peijun Liu

doi:10.1038/s41419-025-08275-8

Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)

Juan Li
, Jie Liu
, Zheyong Liang
, Fang He
, Lu Yang
, Pingping Li
, Yina Jiang
, Bo Wang
, Can Zhou
, Yaochun Wang
, Yu Ren
, Jin Yang
, Jianmin Zhang
, Zhijun Luo
, Cyrus Vaziri
, Peijun Liu

The First Affiliated Hospital of Xi’an Jiaotong University
Roswell Park Cancer Institute
Boston University
University of North Carolina at Chapel Hill

Research output: Contribution to journal › Comment/debate

Abstract

Retraction Note to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.

Original language	English
Article number	860
Journal	Cell Death and Disease
Volume	16
Issue number	1
DOIs	https://doi.org/10.1038/s41419-025-08275-8
State	Published - Dec 2025
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41419-025-08275-8

Fingerprint

Dive into the research topics of 'Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)'. Together they form a unique fingerprint.

Cite this

Li, J., Liu, J., Liang, Z., He, F., Yang, L., Li, P., Jiang, Y., Wang, B., Zhou, C., Wang, Y., Ren, Y., Yang, J., Zhang, J., Luo, Z., Vaziri, C., & Liu, P. (2025). Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46). Cell Death and Disease, 16(1), Article 860. https://doi.org/10.1038/s41419-025-08275-8

@article{37aeedc9fe46444abc3d9399bccf1131,

title = "Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death \& Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)",

abstract = "Retraction Note to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.",

author = "Juan Li and Jie Liu and Zheyong Liang and Fang He and Lu Yang and Pingping Li and Yina Jiang and Bo Wang and Can Zhou and Yaochun Wang and Yu Ren and Jin Yang and Jianmin Zhang and Zhijun Luo and Cyrus Vaziri and Peijun Liu",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = dec,

doi = "10.1038/s41419-025-08275-8",

language = "英语",

volume = "16",

journal = "Cell Death and Disease",

issn = "2041-4889",

publisher = "Springer Nature",

number = "1",

}

Li, J, Liu, J, Liang, Z, He, F, Yang, L, Li, P, Jiang, Y, Wang, B, Zhou, C, Wang, Y, Ren, Y , Yang, J, Zhang, J, Luo, Z, Vaziri, C & Liu, P 2025, 'Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)', Cell Death and Disease, vol. 16, no. 1, 860. https://doi.org/10.1038/s41419-025-08275-8

Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46). / Li, Juan; Liu, Jie; Liang, Zheyong et al.
In: Cell Death and Disease, Vol. 16, No. 1, 860, 12.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Retraction note

T2 - Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)

AU - Li, Juan

AU - Liu, Jie

AU - Liang, Zheyong

AU - He, Fang

AU - Yang, Lu

AU - Li, Pingping

AU - Jiang, Yina

AU - Wang, Bo

AU - Zhou, Can

AU - Wang, Yaochun

AU - Ren, Yu

AU - Yang, Jin

AU - Zhang, Jianmin

AU - Luo, Zhijun

AU - Vaziri, Cyrus

AU - Liu, Peijun

PY - 2025/12

Y1 - 2025/12

N2 - Retraction Note to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.

AB - Retraction Note to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.

UR - https://www.scopus.com/pages/publications/105023232643

U2 - 10.1038/s41419-025-08275-8

DO - 10.1038/s41419-025-08275-8

M3 - 评论/辩论

C2 - 41309534

AN - SCOPUS:105023232643

SN - 2041-4889

VL - 16

JO - Cell Death and Disease

JF - Cell Death and Disease

IS - 1

M1 - 860

ER -

Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this